Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
29
2017
ACTA Update October 27, 2017: Top International News in Chemical Policy and Regulation Bergeson & Campbell, P.C.
Oct
28
2017
EPA to Host Public Meeting to Gather Input on Vertebrate Animal Testing Alternatives Bergeson & Campbell, P.C.
Oct
27
2017
Congressmen Send Bipartisan Letter On Regulating Agricultural Biotechnology To USDA, FDA, EPA Bergeson & Campbell, P.C.
Oct
27
2017
DOE Announces $26 Million In Funding For Carbon Capture Bergeson & Campbell, P.C.
Oct
27
2017
Study: Consumers Confuse “Organic” and “Non-GMO” Labels Keller and Heckman LLP
Oct
27
2017
USDA Awards $7.3 Million In Funding For Agricultural Technologies Bergeson & Campbell, P.C.
Oct
27
2017
BIO Requests Reauthorization Of Biobased Assistance Program Bergeson & Campbell, P.C.
Oct
26
2017
The (R)evolution Can Wait: Implementation of Common Rule Updates May Be Delayed Faegre Drinker
Oct
26
2017
Lawsuits Filed on the Same Day Regarding Amgen’s Avastin® Biosimilar Morgan, Lewis & Bockius LLP
Oct
26
2017
Another State Alleges False Claims Act Violation to Combat Opioid Crisis McDermott Will & Emery
Oct
26
2017
New NARMS Report Shows Mixed Results on Antibiotic Resistance Keller and Heckman LLP
Oct
26
2017
Wisconsin continues to enhance its oversight to impact the opioid epidemic Godfrey & Kahn S.C.
Oct
26
2017
Illinois Businesses Beware: Class Action Suits on the Rise for Alleged Violations of the Illinois Biometric Information Privacy Act ArentFox Schiff LLP
Oct
26
2017
New Jersey Files Lawsuit Against Opioid Manufacturer Stark & Stark
Oct
26
2017
European Trade Union Institute Publishes Policy Brief on EUON Bergeson & Campbell, P.C.
Oct
26
2017
R&H’s Processes for Preparing Emulsion Polymers with Improved Opacity Not Invalid over the Prior Art that Does Not Include a “Swelling Agent” Narrowly Construed by the PTAB Hunton Andrews Kurth
Oct
26
2017
Appeal of Discovery Order in BPCIA Patent Infringement Case Dismissed for Lack of Jurisdiction and Writ of Mandamus for Compelling Discovery Denied Hunton Andrews Kurth
Oct
25
2017
FDA, USDA, and EPA to Hold Public Sessions on Agricultural Biotechnology Bergeson & Campbell, P.C.
Oct
25
2017
Bar Owners Beware: The Hidden Danger of Serving “Just One More” Drink Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
25
2017
New Research Finds Food “Process” Labels Can Stigmatize Conventionally Produced Foods Keller and Heckman LLP
Oct
25
2017
Tracking Anti-Opioid Legislation in Congress Squire Patton Boggs (US) LLP
Oct
24
2017
Government Employee Can Proceed to Trial on Her Challenge to the District of Columbia’s “Blanket” Drug and Alcohol Tests Jackson Lewis P.C.
Oct
24
2017
CFDA Issues New Classification Catalogue for Medical Devices In China Morgan, Lewis & Bockius LLP
Oct
24
2017
FSMA Update: FDA Launches Web Page with Compliance Dates Keller and Heckman LLP
Oct
24
2017
The Unique Explosion Dangers of E-Cigarettes Stark & Stark
Oct
24
2017
Massachusetts Court Upholds Record $2.6M Fine against Beer Distributor McDermott Will & Emery
Oct
24
2017
Federal Circuit Finds NuvaRing Patent Nonobvious Without Hindsight Foley & Lardner LLP
Oct
23
2017
EPA Issues Regulatory Action on Dicamba Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins